The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid diagnostics and consumer markets. Analyze profiles of 60+ companies for informed investment decisions.
The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid diagnostics and consumer markets. Analyze profiles of 60+ companies for informed investment decisions.